Ergoteles’s Coherus Oncology CHRS Stock Holding History

Ergoteles’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$70.9K	Buy
2022 Q2	–	Sell
2022 Q1	$577K	Buy
2021 Q4	$639K	Buy
2021 Q3	$219K	Buy